Lilly, Hospira Settle Gemzar Patent Fight
Eli Lilly & Co. and Hospira Inc. said Tuesday they had reached a settlement in Hospira's Illinois suit seeking a declaration that its planned generic version of cancer drug Gemzar did...To view the full article, register now.
Already a subscriber? Click here to view full article